Trials / Completed
CompletedNCT00723866
Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for Poststroke Upper Extremity Spasticity
Combined Botulinum Toxin Type A With Modified Constraint-Induced Movement Therapy for Chronic Stroke Patients With Upper Extremity Spasticity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Kaohsiung Veterans General Hospital. · Academic / Other
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Botulinum toxin type A (BtxA) injection and modified constraint-induced movement therapy (mCIMT) are both promising approaches to enhance recovery after stroke. However, the combined application of the two modalities has rarely been studied. The aim was to investigate whether combined BtxA and mCIMT would produce greater improvements in spasticity and upper extremity function than BtxA plus conventional rehabilitation in chronic stroke patients with upper extremity spasticity.
Detailed description
Botulinum toxin type A (BtxA) injection and modified constraint-induced movement therapy (mCIMT)are both promising approaches to enhance recovery after stroke. However, the combined application of the two modalities has rarely been studied. To date, only a single case report addressed this issue. Theoretically, application of a mCIMT program with intensive functional tasks practice after spasticity reduction by BtxA may improve affected upper extremity function in patients with poststroke spasticity. The aim was to investigate whether combined BtxA and mCIMT would produce greater improvements in spasticity and upper extremity function than BtxA plus conventional rehabilitation in chronic stroke patients with upper extremity spasticity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | BtxA+mCIMT | The combination group receive BtxA+mCIMT for 2 hours/day, 3 days/week for 3 months. |
| OTHER | BtxA+ conventional rehabilitation | The control group received for 2 hours/day, 3 days/week for 3 months. |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2007-11-01
- Completion
- 2008-06-01
- First posted
- 2008-07-29
- Last updated
- 2008-08-01
Source: ClinicalTrials.gov record NCT00723866. Inclusion in this directory is not an endorsement.